Key points are not available for this paper at this time.
achievement of marked tumor shrinkage," which differs from the treatment concept for other types of advanced cancer or advanced HCC. Upfront Systemic Therapy with Subsequent Locoregional Therapy/Resection in Intermediate-Stage HCC
Masatoshi Kudo (2021) studied this question.